| Lightcalls.com |
|
|
![]() |
As more and more Americans are affe...
Enjoy luxury? Buy the best camping hammocks for sale today.
As more and more Americans are affected from osteoporosis, the disease has received increased attention in the media. The mainstream approach to osteoporosis has focused chiefly on the use of synthetic hormone replacement therapy (HRT) Unfortunately, this solution alone works as long as the unsalable articles are continued indefinitely. recently made known research from Japan suggests that a newly discovered and highly absorbable form of calcium has the power to obviate and reverse bone loss--without dangerous hormonal manipulation. Oyster shell ash breakthrough single independent scientist, Dr. Takuo Fujita, past President of the Osteoporosis Foundation of Japan, has exhausted a considerable part of his career searching for a form of calcium that could be more readily absorbed and used by means of the body. The first breakthrough came in the discovery of a mix called AACa. Early studies showed that AACa was absorbed more than twice as well as calcium carbonate or coral calcium. Exotic algae treatment quadruples the effectiveness if it were not that the real breakthrough came later, when Dr Fujita discovered that the absorbability of AACa could be flat further enhanced by adding HAI, a preparation of specially suited algae. When HAI is added to AACa, the rise is AAACa, an extremely high-potency calcium counterpart that is absorbed four times better than typical calcium carbonate/coral calcium correlatives AAACa is now available in North America in a less degree than the name AdvaCAL[R]. In a lengthy term, double blind study of 58 somewhat advanced in life women, AdvaCAL increased the bone mineral density (BMD) of the spine through over 3 percent after sum of two units years. By comparison, women taking calcium carbonate postscripts experienced only a 0.6 percent increase of spinal BMD and women taking a placebo squandered almost 2 percent. A three percent increase in spinal BMD is an astonishing be the effect particularly when you consider the participants' advanced age. A larger consideration (135 patients suffering from osteoporosis) carriageed by Dr. Fujita indicates that AdvaCAL can actually be used to subvert bone loss once the disease proces has occurred AdvaCAL = Advanced calcium that is small and easy to swallow and digest AdvaCAL is publicly available in a special bonus size (with 25 extra capsules FREE) For more information or to order, call 1-800-7111-5412 or visit your favorite health commons store. [GRAPHIC OMITTED] COPYRIGHT 2004 PRIMEDIA Intertec, a PRIMEDIA Company. All Rights Reserved |
![]() |
Other Articles
-Morphotek will collaborat...-Eksigent Technologies nam... -The benefits of outsourci... -Sartorius Corporation ... -In our previous column, w... -Efoora appointed Michael ... -Affymax appointed Anne-Ma... -Traditionally, continuous... -New Brunswick Scientific ... -The German-American firm ... -Don G. Burstyn, formerly ... -American patients are mor... -Summary Prior to va... -BioPharm Editorial Adviso... -Australia agreed to spend... -The Biotechnology Industr... -Ambion, The RNA Company i... -Therapies based on living... -A recent survey found tha... -ViroLogic will acquire Ac... -Cardinal Health named Joh... -One of the greatest chall... -As the president of a sma... -Sweden-based Biovitrum wi... -Nanogen appointed David L... -The Experion Process Know... -Although biomedical resea... -The Supreme Court of Cana... -Netherlands-based DSM Bio... -David A. Smoller joined S... -A few months ago, I wrote... -Panacos Pharmaceuticals w... -Karen K. Vaccaro will res... -Acceleron Pharma appointe... -Two quarterly meetings of... -Illinois-based Abbot Labo... -FKI Logistics announced t... -The following corrections... -It its widest definition,... -UK-based Xcellsyz will li... -Andrew P. Aromando joined... -Invitrogen's comprehensiv... -Last month, we described ... -The Swiss life sciences c... -Protein Design Labs (PDL)... -Model It HNMR, the newest... -Tech transfer, like chang... -QLT and Atrix Laboratorie... -Dendreon announced Christ... -Baxter Pharmaceutical Sol... -The biopharmaceutical ind... -GlaxoSmithKline announced... -Montreal-based Caprion Ph... -Xenova Group recently ann... -Cole-Parmer's new 192-pag... -Over the last decade ther... -Benchmark your facility p... -As biotechnology organiza... -Frederick D. Sancillo, fo... -Insmed acquired a recombi... -Baxter Pharmaceutical Sol... -Model It HNMR, the newest... -DA's regulation 21 CFR Pa... -Robert P. Ryan joined Ath... -A new report from Busines... -Biotest offers a complete... -Swagelok offers a brochur... -Partnering is a global ph... -Human Genome Sciences CEO... -Shorten the process devel... -The licensure of biotechn... -Rodger Currie joined Amge... -The GEA Filtration Model ... -A multi-channel chemistry... -From June 6-9, San Franci... -Skanska USA Building Inc.... -New Brunswick Scientific'... -AVI BioPharma appointed P... -Ambion, The RNA Company, ... -"If you want to be a... -Xcellerex appointed Susan... -Researchers identified th... -Cool Spring Business Park... -In October 2003, Shenzhen... -Laureate Pharma appointed... -After a 6-5 vote by Calif... -QSourcing, a service of Q... -The recent discovery of &... -Affymax added Douglas L. ... -USDA recently approved tw... -BioPharm International is... -Serologicals has released... -This document by Shenzhen... -Robert Bronstein joined A... -Gloucester Gains Fujisawa... -With more than 30 years o... -Pall's SUPRAdisc II depth... -In today's competitive ma... -Protein Design Labs repor... -Charles A. Rice will repl... -AstraZeneca's Faslodex (f... |
| . |